Alpha-1 antitrypsin investigations using animal models of emphysema

Kevin Ni, Karina A. Serban, Chanan Batra, Irina Petrache

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Animal models of disease help accelerate the translation of basic science discoveries to the bedside, because they permit experimental interrogation of mechanisms at relatively high throughput, while accounting for the complexity of an intact organism. From the groundbreaking observation of emphysema-like alveolar destruction after direct instillation of elastase in the lungs to the more clinically relevant model of airspace enlargement induced by chronic exposure to cigarette smoke, animal models have advanced our understanding of alpha-1 antitrypsin (AAT) function. Experimental in vivo models that, at least in part, replicate clinical human phenotypes facilitate the translation of mechanistic findings into individuals with chronic obstructive pulmonary disease and with AAT deficiency. In addition, unexpected findings of alveolar enlargement in various transgenic mice have led to novel hypotheses of emphysema development. Previous challenges in manipulating the AAT genes in mice can now be overcome with new transgenic approaches that will likely advance our understanding of functions of this essential, lung-protective serine protease inhibitor (serpin).

Original languageEnglish (US)
Pages (from-to)S311-S316
JournalAnnals of the American Thoracic Society
Volume13
DOIs
StatePublished - Aug 1 2016
Externally publishedYes

Fingerprint

alpha 1-Antitrypsin
Emphysema
Animal Models
alpha 1-Antitrypsin Deficiency
Animal Disease Models
Lung
Serine Proteinase Inhibitors
Pancreatic Elastase
Smoke
Tobacco Products
Chronic Obstructive Pulmonary Disease
Transgenic Mice
Observation
Phenotype
Genes
Autosomal Recessive alpha-1-Antitrypsin Deficiency

Keywords

  • Alpha-1 antiproteinase
  • Chronic obstructive pulmonary disease
  • Emphysema

ASJC Scopus subject areas

  • Medicine(all)
  • Pulmonary and Respiratory Medicine

Cite this

Alpha-1 antitrypsin investigations using animal models of emphysema. / Ni, Kevin; Serban, Karina A.; Batra, Chanan; Petrache, Irina.

In: Annals of the American Thoracic Society, Vol. 13, 01.08.2016, p. S311-S316.

Research output: Contribution to journalArticle

Ni, Kevin ; Serban, Karina A. ; Batra, Chanan ; Petrache, Irina. / Alpha-1 antitrypsin investigations using animal models of emphysema. In: Annals of the American Thoracic Society. 2016 ; Vol. 13. pp. S311-S316.
@article{85e08367931e40d79c7e0d4c9d96fd19,
title = "Alpha-1 antitrypsin investigations using animal models of emphysema",
abstract = "Animal models of disease help accelerate the translation of basic science discoveries to the bedside, because they permit experimental interrogation of mechanisms at relatively high throughput, while accounting for the complexity of an intact organism. From the groundbreaking observation of emphysema-like alveolar destruction after direct instillation of elastase in the lungs to the more clinically relevant model of airspace enlargement induced by chronic exposure to cigarette smoke, animal models have advanced our understanding of alpha-1 antitrypsin (AAT) function. Experimental in vivo models that, at least in part, replicate clinical human phenotypes facilitate the translation of mechanistic findings into individuals with chronic obstructive pulmonary disease and with AAT deficiency. In addition, unexpected findings of alveolar enlargement in various transgenic mice have led to novel hypotheses of emphysema development. Previous challenges in manipulating the AAT genes in mice can now be overcome with new transgenic approaches that will likely advance our understanding of functions of this essential, lung-protective serine protease inhibitor (serpin).",
keywords = "Alpha-1 antiproteinase, Chronic obstructive pulmonary disease, Emphysema",
author = "Kevin Ni and Serban, {Karina A.} and Chanan Batra and Irina Petrache",
year = "2016",
month = "8",
day = "1",
doi = "10.1513/AnnalsATS.201510-675KV",
language = "English (US)",
volume = "13",
pages = "S311--S316",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",

}

TY - JOUR

T1 - Alpha-1 antitrypsin investigations using animal models of emphysema

AU - Ni, Kevin

AU - Serban, Karina A.

AU - Batra, Chanan

AU - Petrache, Irina

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Animal models of disease help accelerate the translation of basic science discoveries to the bedside, because they permit experimental interrogation of mechanisms at relatively high throughput, while accounting for the complexity of an intact organism. From the groundbreaking observation of emphysema-like alveolar destruction after direct instillation of elastase in the lungs to the more clinically relevant model of airspace enlargement induced by chronic exposure to cigarette smoke, animal models have advanced our understanding of alpha-1 antitrypsin (AAT) function. Experimental in vivo models that, at least in part, replicate clinical human phenotypes facilitate the translation of mechanistic findings into individuals with chronic obstructive pulmonary disease and with AAT deficiency. In addition, unexpected findings of alveolar enlargement in various transgenic mice have led to novel hypotheses of emphysema development. Previous challenges in manipulating the AAT genes in mice can now be overcome with new transgenic approaches that will likely advance our understanding of functions of this essential, lung-protective serine protease inhibitor (serpin).

AB - Animal models of disease help accelerate the translation of basic science discoveries to the bedside, because they permit experimental interrogation of mechanisms at relatively high throughput, while accounting for the complexity of an intact organism. From the groundbreaking observation of emphysema-like alveolar destruction after direct instillation of elastase in the lungs to the more clinically relevant model of airspace enlargement induced by chronic exposure to cigarette smoke, animal models have advanced our understanding of alpha-1 antitrypsin (AAT) function. Experimental in vivo models that, at least in part, replicate clinical human phenotypes facilitate the translation of mechanistic findings into individuals with chronic obstructive pulmonary disease and with AAT deficiency. In addition, unexpected findings of alveolar enlargement in various transgenic mice have led to novel hypotheses of emphysema development. Previous challenges in manipulating the AAT genes in mice can now be overcome with new transgenic approaches that will likely advance our understanding of functions of this essential, lung-protective serine protease inhibitor (serpin).

KW - Alpha-1 antiproteinase

KW - Chronic obstructive pulmonary disease

KW - Emphysema

UR - http://www.scopus.com/inward/record.url?scp=84989858346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989858346&partnerID=8YFLogxK

U2 - 10.1513/AnnalsATS.201510-675KV

DO - 10.1513/AnnalsATS.201510-675KV

M3 - Article

C2 - 27564666

AN - SCOPUS:84989858346

VL - 13

SP - S311-S316

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

ER -